ProShare Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $15.1K | Sell |
|
|||||
|
2024
Q1 | $21.6K | Buy |
|
|||||
|
2023
Q4 | $16.8K | Buy |
|
|||||
|
2023
Q3 | $93.6K | Buy |
|
|||||
|
2023
Q2 | $141K | Buy |
|
|||||
|
2023
Q1 | $98.9K | Sell |
|
|||||
|
2022
Q4 | $218K | Buy |
|
|||||
|
2022
Q3 | $201K | Buy |
|
|||||
|
2022
Q2 | $167K | Sell |
|
|||||
|
2022
Q1 | $274K | Sell |
|
|||||
|
2021
Q4 | $287K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $198K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $16K | Sell |
|
|||||
|
2019
Q2 | $35K | Sell |
|
|||||
|
2019
Q1 | $106K | Buy |
|
|||||
|
2018
Q4 | $130K | Buy |
|
|||||
|
2018
Q3 | $231K | Sell |
|
|||||
|
2018
Q2 | $330K | Sell |
|
|||||
|
2018
Q1 | $302K | Sell |
|
|||||
|
2017
Q4 | $495K | Buy |
|